
|Articles|February 1, 2005
Old therapy offers new hope for skin disease
Everything old is new again could be the theme of a promising new therapy for sufferers of immune-mediated skin disease — CellCept?. P. R?gine Mydlarski, M.D., F.R.C.P.C., assistant professor at the University of Calgary, says the reformulation of medication that has been around for nearly a century is an up-and-coming treatment for skin conditions in the hands of the dermatologist.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
2
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
3
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
4
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
5


















